Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
37
FDA:34
NMPA:3
Drug Approvals
Oxycodone and Acetaminophen Tablets
- Product Name
- 泰勒宁
- Approval Number
- 国药准字HJ20181190
- Approval Date
- Jul 7, 2020
NMPA
Oxycodone and Acetaminophen Tablets
- Product Name
- 泰勒宁
- Approval Number
- 国药准字HJ20181186
- Approval Date
- Jul 7, 2020
NMPA
Oxycodone and Acetaminophen Tablets
- Product Name
- 泰勒宁
- Approval Number
- J20171086
- Approval Date
- Jul 2, 2018
NMPA
Clinical Trials
No trials found
News
FDA Rejects Mallinckrodt's Abuse-Deterrent Roxicodone Reformulation
The FDA issued a Complete Response Letter for SpecGx LLC's abuse-deterrent, immediate-release reformulation of Roxicodone (oxycodone hydrochloride) tablets.